{"id":74905,"date":"2020-04-17T09:27:11","date_gmt":"2020-04-17T14:27:11","guid":{"rendered":"https:\/\/pulmonx.com\/trayectoria-de-pulmonx\/"},"modified":"2020-05-13T12:10:10","modified_gmt":"2020-05-13T17:10:10","slug":"trayectoria-de-pulmonx","status":"publish","type":"page","link":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/","title":{"rendered":"Trayectoria de Pulmonx"},"content":{"rendered":"<!--themify_builder_content-->\n<div id=\"themify_builder_content-74905\" data-postid=\"74905\" class=\"themify_builder_content themify_builder_content-74905 themify_builder tf_clear\">\n                    <div  data-lazy=\"1\" class=\"module_row themify_builder_row tb_mpt8238 tb_first tf_w\">\n                        <div class=\"row_inner col_align_top tb_col_count_1 tf_box tf_rel\">\n                        <div  data-lazy=\"1\" class=\"module_column tb-column col-full tb_vi8h239 first\">\n                    <!-- module timeline -->\n<div  id=\"tb_wnzx531\" class=\"module tf_hidden tf_lazy module-timeline tb_wnzx531 layout-list \" data-lazy=\"1\">\n    <ul class=\"tf_rel\">\n\t\t\t<li id=\"timeline-0\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2019\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-certificate\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-certificate\" xlink:href=\"#tf-fas-certificate\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Categor\u00eda de evidencia \u201cA\u201d concedido por la GOLD\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p><img decoding=\"async\" class=\"alignnone size-medium wp-image-117\" src=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png\" alt=\"\" width=\"300\" height=\"145\" srcset=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png 300w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-768x371.png 768w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-350x168.png 350w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve.png 800w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>La categor\u00eda de evidencia \u201cA\u201d de la GOLD declara que las v\u00e1lvulas endobronquiales, como la v\u00e1lvula\u00a0Zephyr<sup>\u00ae<\/sup>, son una opci\u00f3n de tratamiento m\u00ednimamente invasivo viable para el enfisema grave, una forma de la EPOC.<\/p>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-1\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2019\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-far-calendar-check-o\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-far-calendar-check-o\" xlink:href=\"#tf-far-calendar-check-o\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Aprobaci\u00f3n de la 5.5-LP\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p><img decoding=\"async\" class=\"alignnone wp-image-290\" src=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/5.5-LP-Valve-Approval-2019-300x300.jpg\" alt=\"\" width=\"233\" height=\"233\" srcset=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/5.5-LP-Valve-Approval-2019-300x300.jpg 300w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/5.5-LP-Valve-Approval-2019-150x150.jpg 150w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/5.5-LP-Valve-Approval-2019.jpg 636w\" sizes=\"(max-width: 233px) 100vw, 233px\" \/><br \/>V\u00e1lvula\u00a0Zephyr\u00a05.5-LP aprobada para su uso en EE.\u00a0UU.<\/p>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-2\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2018\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-flag-usa\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-flag-usa\" xlink:href=\"#tf-fas-flag-usa\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Aprobaci\u00f3n de la FDA de EE. UU.\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <h3><img decoding=\"async\" class=\"alignnone wp-image-295\" src=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/Zephyr-Valve-US-FDA-Approval-300x150.jpg\" alt=\"\" width=\"378\" height=\"189\" srcset=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/Zephyr-Valve-US-FDA-Approval-300x150.jpg 300w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/Zephyr-Valve-US-FDA-Approval-768x383.jpg 768w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/Zephyr-Valve-US-FDA-Approval-1024x511.jpg 1024w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/10\/Zephyr-Valve-US-FDA-Approval.jpg 1200w\" sizes=\"(max-width: 378px) 100vw, 378px\" \/><\/h3>\n<ul>\n<li>Aprobaci\u00f3n de la FDA de la v\u00e1lvula Zephyr en Estados Unidos.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>20<\/sup><\/a><\/li>\n<li>Resultados del ECA multic\u00e9ntrico y multinacional <strong>LIBERATE<\/strong>\u00a0publicados en Blue Journal que demuestran beneficios cl\u00ednica y estad\u00edsticamente significativos con respecto al tratamiento m\u00e9dico de referencia al producir mejoras en la funci\u00f3n pulmonar, la tolerancia al ejercicio, la calidad de vida y la disnea.<\/li>\n<\/ul>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-3\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2017\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-stethoscope\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-stethoscope\" xlink:href=\"#tf-fas-stethoscope\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Beneficios cl\u00ednicos\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p>Los datos presentados de dos ECA multic\u00e9ntricos demostraron beneficios cl\u00ednicos significativos para pacientes con enfisema heterog\u00e9neo y homog\u00e9neo sin ventilaci\u00f3n colateral.<\/p>\n<ul>\n<li>La GOLD incluye la v\u00e1lvula Zephyr en sus recomendaciones de tratamiento de la EPOC.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>9<\/sup><\/a><\/li>\n<li>Respiration publica resultados positivos de 1 a\u00f1o de <strong>STELVIO<\/strong>, primer ECA de Zephyr en el que se utiliz\u00f3 el sistema Chartis para la selecci\u00f3n de pacientes.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>5<\/sup><\/a><\/li>\n<li>Blue Journal publica resultados de\u00a0<strong>TRANSFORM<\/strong>, ECA multic\u00e9ntrico y multinacional en el que se demostr\u00f3 que la v\u00e1lvula Zephyr ofrec\u00eda beneficios similares a los de la CRVP, adem\u00e1s de una posible disminuci\u00f3n de la morbilidad despu\u00e9s del procedimiento para pacientes que siguen sintom\u00e1ticos a pesar del tratamiento m\u00e9dico m\u00e1ximo.<\/li>\n<\/ul>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-4\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2016\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-list-alt\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-list-alt\" xlink:href=\"#tf-fas-list-alt\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Evidencia cl\u00ednica documentada\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <ul>\n<li>El ECA <strong>IMPACT<\/strong> de pacientes con enfisema homog\u00e9neo se publica en Blue Journal y demuestra beneficios cl\u00ednicamente significativos de la funci\u00f3n pulmonar, la tolerancia al ejercicio y la calidad de vida.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>3<\/sup><\/a><\/li>\n<li>Se lanza la plataforma de an\u00e1lisis pulmonar StratX<sup>\u00ae<\/sup>.<\/li>\n<\/ul>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-5\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2015\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-user-friends\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-user-friends\" xlink:href=\"#tf-fas-user-friends\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Logros obtenidos en pacientes\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <ul>\n<li><em>The New England Journal of Medicine <\/em>publica los resultados del ensayo STELVIO, en el que se utiliz\u00f3 Chartis<sup>\u00ae<\/sup> para preseleccionar a los candidatos para el tratamiento con v\u00e1lvulas Zephyr y que demostr\u00f3 mejoras cl\u00ednica y estad\u00edsticamente significativas de la funci\u00f3n pulmonar, la capacidad de ejercicio y la calidad de vida en el grupo tratado con respecto al tratamiento de referencia.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>4<\/sup><\/a><\/li>\n<li>The Lancet publica el primer ensayo controlado con tratamiento simulado realizado con \u00e9xito de un dispositivo para tratar de forma m\u00ednimamente invasiva el enfisema (Zephyr), BeLieVeR-HIFi.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>16<\/sup><\/a><\/li>\n<\/ul>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-6\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2014\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-building\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-building\" xlink:href=\"#tf-fas-building\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Adquisici\u00f3n de Aeris Therapeutics\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p>Adquisici\u00f3n de activos de Therapeutics, incluido AeriSeal.<\/p>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-7\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2013\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-newspaper\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-newspaper\" xlink:href=\"#tf-fas-newspaper\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Publicaci\u00f3n de un ensayo multic\u00e9ntrico de Chartis\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p><img decoding=\"async\" class=\"alignnone size-medium wp-image-133\" src=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Chartis-Tablet-Pulmonx-Technology-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Chartis-Tablet-Pulmonx-Technology-300x300.png 300w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Chartis-Tablet-Pulmonx-Technology-150x150.png 150w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Chartis-Tablet-Pulmonx-Technology-768x768.png 768w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Chartis-Tablet-Pulmonx-Technology-400x400.png 400w, https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Chartis-Tablet-Pulmonx-Technology.png 800w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><em>European Respiratory Journal <\/em>publica un ensayo multic\u00e9ntrico del sistema Chartis en el que se demuestra su capacidad para predecir qu\u00e9 pacientes pueden responder al tratamiento con v\u00e1lvulas Zephyr.<a href=\"\/es\/referencias\/\"><sup>33<\/sup><\/a><\/p>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-8\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2010\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-laptop-medical\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-laptop-medical\" xlink:href=\"#tf-fas-laptop-medical\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Primer ensayo cl\u00ednico aleatorizado de Zephyr publicado\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p><em>New England Journal of Medicine<\/em> publica el primer ensayo aleatorizado de Zephyr.<a style=\"font-size: 15px;\" href=\"\/es\/referencias\/\"><sup>17<\/sup><\/a><\/p>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-9\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2009\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-certificate\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-certificate\" xlink:href=\"#tf-fas-certificate\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Marca CE para Chartis\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t <p>El sistema Chartis recibe la marca\u00a0CE.<\/p>\t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t\t\t<li id=\"timeline-10\" class=\"timeline-post with-icon \">\n\t\t\t<span class=\"module-timeline-date tf_box tf_textr\">\n\t\t\t\t\t  2003\t\t\t<\/span>\n\t\t\t\t\t\t\t<i class=\"module-timeline-icon\" style=\"background-color:#3095b4;\"><svg  class=\"tf_fa tf-fas-certificate\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" aria-hidden=\"true\"><use href=\"#tf-fas-certificate\" xlink:href=\"#tf-fas-certificate\"><\/use><\/svg><\/i>\n\n\t\t\t\t\t\t<div class=\"module-timeline-content-wrap tf_box tf_right\">\n\t\t\t\t<div class=\"module-timeline-content\">\n\t\t\t\t\t\t\t\t\t\t\t<h2 class=\"module-timeline-title\">    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t   Marca CE para Zephyr\t\t\t\t\t\t\t   \t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"entry-content\" itemprop=\"articleBody\">\n\t\t\t\t\t\t\t\t \t\t\t\t\t\t<\/div><!-- \/.entry-content -->\n\t\t\t\t\t\t\t\t\t<\/div><!-- \/.timeline-content -->\n\t\t\t<\/div><!-- \/.timeline-content-wrap -->\n\t\t<\/li>\n\t<\/ul><\/div>\n<!-- \/module timeline -->        <\/div>\n                        <\/div>\n        <\/div>\n        <\/div>\n<!--\/themify_builder_content-->","protected":false},"excerpt":{"rendered":"<p>2019 Categor\u00eda de evidencia \u201cA\u201d concedido por la GOLD La categor\u00eda de evidencia \u201cA\u201d de la GOLD declara que las v\u00e1lvulas endobronquiales, como la v\u00e1lvula\u00a0Zephyr\u00ae, son una opci\u00f3n de tratamiento m\u00ednimamente invasivo viable para el enfisema grave, una forma de la EPOC. 2019 Aprobaci\u00f3n de la 5.5-LP V\u00e1lvula\u00a0Zephyr\u00a05.5-LP aprobada para su uso en EE.\u00a0UU. 2018 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-74905","page","type-page","status-publish","hentry","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trayectoria de Pulmonx - Pulmonx<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trayectoria de Pulmonx - Pulmonx\" \/>\n<meta property=\"og:description\" content=\"2019 Categor\u00eda de evidencia \u201cA\u201d concedido por la GOLD La categor\u00eda de evidencia \u201cA\u201d de la GOLD declara que las v\u00e1lvulas endobronquiales, como la v\u00e1lvula\u00a0Zephyr\u00ae, son una opci\u00f3n de tratamiento m\u00ednimamente invasivo viable para el enfisema grave, una forma de la EPOC. 2019 Aprobaci\u00f3n de la 5.5-LP V\u00e1lvula\u00a0Zephyr\u00a05.5-LP aprobada para su uso en EE.\u00a0UU. 2018 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/\" \/>\n<meta property=\"og:site_name\" content=\"Pulmonx\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Mylungsmylife\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-13T17:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@my_lungs\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/\",\"name\":\"Trayectoria de Pulmonx - Pulmonx\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/GOLD-Guidelines-Zephyr-Valve-300x145.png\",\"datePublished\":\"2020-04-17T14:27:11+00:00\",\"dateModified\":\"2020-05-13T17:10:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/GOLD-Guidelines-Zephyr-Valve-300x145.png\",\"contentUrl\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/GOLD-Guidelines-Zephyr-Valve-300x145.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/trayectoria-de-pulmonx\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trayectoria de Pulmonx\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/\",\"name\":\"Pulmonx\",\"description\":\"Helping Patients with COPD Breathe Easier\",\"publisher\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/#organization\",\"name\":\"Pulmonx Corporation\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/Logo-RGB.png\",\"contentUrl\":\"https:\\\/\\\/pulmonx.com\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/Logo-RGB.png\",\"width\":566,\"height\":217,\"caption\":\"Pulmonx Corporation\"},\"image\":{\"@id\":\"https:\\\/\\\/pulmonx.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Mylungsmylife\",\"https:\\\/\\\/x.com\\\/my_lungs\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pulmonx\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCOcSdewvx6iquPm_XcaYI5Q\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trayectoria de Pulmonx - Pulmonx","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/","og_locale":"es_ES","og_type":"article","og_title":"Trayectoria de Pulmonx - Pulmonx","og_description":"2019 Categor\u00eda de evidencia \u201cA\u201d concedido por la GOLD La categor\u00eda de evidencia \u201cA\u201d de la GOLD declara que las v\u00e1lvulas endobronquiales, como la v\u00e1lvula\u00a0Zephyr\u00ae, son una opci\u00f3n de tratamiento m\u00ednimamente invasivo viable para el enfisema grave, una forma de la EPOC. 2019 Aprobaci\u00f3n de la 5.5-LP V\u00e1lvula\u00a0Zephyr\u00a05.5-LP aprobada para su uso en EE.\u00a0UU. 2018 [&hellip;]","og_url":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/","og_site_name":"Pulmonx","article_publisher":"https:\/\/www.facebook.com\/Mylungsmylife","article_modified_time":"2020-05-13T17:10:10+00:00","og_image":[{"url":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@my_lungs","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/","url":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/","name":"Trayectoria de Pulmonx - Pulmonx","isPartOf":{"@id":"https:\/\/pulmonx.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/#primaryimage"},"image":{"@id":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/#primaryimage"},"thumbnailUrl":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png","datePublished":"2020-04-17T14:27:11+00:00","dateModified":"2020-05-13T17:10:10+00:00","breadcrumb":{"@id":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/#primaryimage","url":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png","contentUrl":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/GOLD-Guidelines-Zephyr-Valve-300x145.png"},{"@type":"BreadcrumbList","@id":"https:\/\/pulmonx.com\/es\/trayectoria-de-pulmonx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pulmonx.com\/es\/"},{"@type":"ListItem","position":2,"name":"Trayectoria de Pulmonx"}]},{"@type":"WebSite","@id":"https:\/\/pulmonx.com\/es\/#website","url":"https:\/\/pulmonx.com\/es\/","name":"Pulmonx","description":"Helping Patients with COPD Breathe Easier","publisher":{"@id":"https:\/\/pulmonx.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pulmonx.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/pulmonx.com\/es\/#organization","name":"Pulmonx Corporation","url":"https:\/\/pulmonx.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pulmonx.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Logo-RGB.png","contentUrl":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/Logo-RGB.png","width":566,"height":217,"caption":"Pulmonx Corporation"},"image":{"@id":"https:\/\/pulmonx.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Mylungsmylife","https:\/\/x.com\/my_lungs","https:\/\/www.linkedin.com\/company\/pulmonx","https:\/\/www.youtube.com\/channel\/UCOcSdewvx6iquPm_XcaYI5Q"]}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Pulmonx","distributor_original_site_url":"https:\/\/pulmonx.com\/es\/","push-errors":false,"_links":{"self":[{"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/pages\/74905","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/comments?post=74905"}],"version-history":[{"count":0,"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/pages\/74905\/revisions"}],"wp:attachment":[{"href":"https:\/\/pulmonx.com\/es\/wp-json\/wp\/v2\/media?parent=74905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}